Vaccine 4 1 1 for 7-20-2020 - tracking the race to find a cure for the Coronavirus - Covid 19

<p>On this episode of Vaccine 411……Can cannabis calm the Cytokine Storm?</p><p>First, the latest vaccine news from around the world:</p><p>United States:&nbsp;Kentucky BioProcessing has entered Phase I clinical trials for their tobacco-based vaccine.&nbsp;The tobacco plant is engineered to make viral proteins.</p><p>&nbsp;107,000 people have signed up for clinical trials for a COVID-19 vaccine, at least 120,00 are needed by the fall for Phase III trials for 4 potential vaccines.&nbsp;</p><p>United Kingdom: Oxford University/Astra Zeneca released positive data on their early stage trials, noting that it has produced promising response in large early stage trials.&nbsp;They are currently in Phase III trials in the UK, Brazil &amp; South Africa and will begin a U.S. trial soon.&nbsp;</p><p>The UK has secured an additional 90 million doses of potential COVID-19 vaccines by partnering with BioNtech/Pfizer and Valneva.&nbsp;This is in addition to their partnership with University of Oxford/AstraZeneca.&nbsp;</p><p>Synairgen, announced they may have a potential new treatment for COVID-19.&nbsp;The Southampton based biotech company presented research that their inhaled drug lowered the risk of a severe case of COVID-19 by 79%, reports The Washington Post.&nbsp;The study has not been peer reviewed.&nbsp;</p><p>North Korea:&nbsp;The State Commission of Science and Technology posted on their website that they have started Phase I clinical trials on a vaccine candidate.&nbsp;Though no data was provided.&nbsp;&nbsp;</p> &#10;&nbsp;<br /><hr><p style='color: grey; font - size: 0.75em; '>See <a style='color: grey; ' target='_blank' rel='noopener noreferrer' href='https://acast.com/privacy'>acast.com/privacy</a> for privacy and opt-out information.</p>